OTC PRODUCTS - AN OVERVIEW

This article opinions the mechanism of motion, resistance, pharmacokinetics, and adverse results of every of such courses, as well as latest treatment suggestions for his or her use in Grown ups and adolescents with HIV infection.The FDA approved in 2021 rilpivirine IM and cabotegravir IM as a whole once regular monthly program for treatment of HIV